Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shocking new hope: electrical suit boosts stroke walking

NCT ID NCT07218107

Symptom relief Sponsor: Boston University Charles River Campus Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This small study tested whether a wearable device that uses electrical stimulation can help people who had a stroke walk farther and more efficiently. Four participants completed 12 training sessions over 4-5 weeks. The goal was to see if the device is practical and improves walking endurance and symmetry.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

4 people

The number who actually took part.

Started

Jun 2024

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 - 80 years old * History of stroke event occurring at least 6 months ago * Observable gait deficits characteristic of post-stroke hemiparesis * Independent ambulation for at least 30 meters (with an assistive device if needed but without a rigid brace for the ankle) * Ankle dorsiflexion range of motion at least to neutral (i.e., 90 degrees between the shank and the foot) * Resting heart rate between 40 - 100 bpm (inclusive) * Resting blood pressure between 90/60 and 170/90 mmHg (inclusive) * HIPAA authorization to allow communication with healthcare provider as needed during the study period * Medical clearance by a physician Exclusion Criteria: * NIH Stroke Scale Question 1b score \> 1 and Question 1c score \> 0 * Inability to communicate with investigators * Visual neglect or hemianopia * History of cerebellar stroke * Actively receiving physical therapy for walking * More than 2 unexplained falls in the previous month * Pressure ulcers or skin wounds located near human-device interface sites * Pacemakers or similar electrical implants that could be affected by electrical stimulation * Metal implants directly under the stimulation sites * Skin allergy or other condition sensitive to the adhesive from transcutaneous neurostimulation electrode pads * Other medical, orthopedic, and neurological conditions that prevent full participation in the research

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

Contacts and locations

Locations

  • Center for Neurorehabilitation

    Boston, Massachusetts, 02215, United States

  • Neuromotor Recovery Laboratory

    Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.